NaultJC, DattaS, ImbeaudS, et al.Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet, 2015; 47:1187–1193.
2.
StrattonMR, CampbellPJ, FutrealPA. The cancer genome. Nature, 2009; 458:719–724.
3.
OstroveJM, DuckworthDH, BernsKI. Inhibition of adenovirus-transformed cell oncogenicity by adeno-associated virus. Virology, 1981; 113:521–533.
4.
MayorHD, DrakeS, StahmannJ, et al.Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am J Obstet Gynecol, 1976; 126:100–104.
5.
HermonatPL. Inhibition of H-ras expression by the adeno-associated virus Rep78 transformation suppressor gene product. Cancer Res, 1991; 51:3373–3377.
6.
LuoJ, LuoY, SunJ, et al.Adeno-associated virus-mediated cancer gene therapy: Current status. Cancer Lett, 2015; 356:347–356.
7.
FreitasLB, Tonani de MattosA, LimaBM, et al.Adeno-associated virus may play a protective role against human papillomavirus-induced cervical lesions independent of HIV serostatus. Int J STD AIDS, 2012; 23:258–261.
8.
NaultJC, MalletM, PilatiC, et al.High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions. Nat Commun, 2013; 4:2218.
9.
SungWK, ZhengH, LiS, et al.Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet, 2012; 44:765–769.
10.
SchulzeK, ImbeaudS, LetouzeE, et al.Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet, 2015; 47:505–511.
11.
HuangFW, HodisE, XuMJ, et al.Highly recurrent TERT promoter mutations in human melanoma. Science, 2013; 339:957–959.
12.
VinagreJ, PintoV, CelestinoR, et al.Telomerase promoter mutations in cancer: An emerging molecular biomarker?. Virchows Archiv, 2014; 465:119–133.
13.
MoorePS, ChangY. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer, 2010; 10:878–889.
DingD, LouX, HuaD, et al.Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PLoS Genet, 2012; 8:e1003065.
